The drug commonly used for Her2-positive breast cancers may actually turn ER-negative status into positive. It’s a two-step process, though, and the research was done on ER-negative, Her2-positive laboratory cells, not on human subjects. Still, it offers amazing potential and could ultimately provide much-needed therapy for hormone-negative breast cancer, including triple negative.
After being treated with trastuzumab (Herceptin), ER-negative cells actually turned into ER-positive cells, making them then react to anti-estrogen drugs like tamoxifen and aromatase inhibitors, according to research presented at the Endocrine Society meeting this month.
The research was done in vitro—in a lab, on existing cells, rather than in human subjects. Cells were ER-negative, Her2-postive and were treated with trastuzumab; after 72 hours they were treated with the hormones estradiol and androstenedione. After that they were given aromatase inhibitors and antiestrogens.
The tumors then reacted in much the way ER-positive tumors do to aromatase inhibitors and antiestrogens.
Read more about the study here.
SOURCE: Sabnis G, Brodie A "Trastuzumab sensitizes ER negative, HER-2 positive breast cancer cells (SKBr-3) to endocrine therapy" ENDO 2009; Abstract OR38-02.
Great blog! I added you to my blogroll, Cancer Blog Links at www.beingcancer.net. Also...Open invitation to you and your readers to participate in the Being Cancer Book Club. This month we are discussing “The Last Lecture” by Randy Pausch. “...the lecture he gave ... was about the importance of overcoming obstacles, of enabling the dreams of others, of seizing every moment (because “time is all you have…and you may find one day that you have less than you think”). It was a summation of everything Randy had come to believe. It was about living.”
Monday is Book Club day; Wednesday Guest Blog and Friday Cancer News Roundup.
Also check out Cancer Blog Links containing over 285 blog links and Cancer Resources with 230 referenced sites, both divided into disease categories.
Please accept this invitation to join our growing cancer blogging community at www.beingcancer.net
Take care, Dennis
Post a Comment